Renal transplant
Not yet recruitingStudy on Optimizing Immunosuppressive Treatment for Living Donor Kidney Transplant Patients Using Prednisone, Basiliximab, and Tacrolimus Monohydrate
Study on Optimizing Immunosuppressive Treatment for Living Donor Kidney Transplant Patients Using Prednisone, Basiliximab, and Tacrolimus Monohydrate
- Disease:Renal transplant
- Substances:BasiliximabMethylprednisolone+4
Spain- Participants:18–64 years · 65+ years
- Substances:Basiliximab
- Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca








